NZ599559A - Methods and compositions for rapid treatment of otitis externa - Google Patents

Methods and compositions for rapid treatment of otitis externa

Info

Publication number
NZ599559A
NZ599559A NZ599559A NZ59955910A NZ599559A NZ 599559 A NZ599559 A NZ 599559A NZ 599559 A NZ599559 A NZ 599559A NZ 59955910 A NZ59955910 A NZ 59955910A NZ 599559 A NZ599559 A NZ 599559A
Authority
NZ
New Zealand
Prior art keywords
lipid
composition
active agents
otitis externa
compositions
Prior art date
Application number
NZ599559A
Other languages
English (en)
Inventor
Neil E Paulsen
Roland H Johnson
William R Campbell
Douglas I Hepler
Original Assignee
Bayer Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43992011&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ599559(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Bv filed Critical Bayer Bv
Publication of NZ599559A publication Critical patent/NZ599559A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ599559A 2009-11-11 2010-11-10 Methods and compositions for rapid treatment of otitis externa NZ599559A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26030909P 2009-11-11 2009-11-11
PCT/US2010/056255 WO2011060083A1 (en) 2009-11-11 2010-11-10 Methods and compositions for rapid treatment of otitis externa

Publications (1)

Publication Number Publication Date
NZ599559A true NZ599559A (en) 2014-08-29

Family

ID=43992011

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ599559A NZ599559A (en) 2009-11-11 2010-11-10 Methods and compositions for rapid treatment of otitis externa

Country Status (29)

Country Link
US (1) US8927006B2 (enExample)
EP (1) EP2498792B1 (enExample)
JP (2) JP2013510861A (enExample)
KR (2) KR20120116398A (enExample)
CN (1) CN102612372B (enExample)
AU (1) AU2010319538B2 (enExample)
BR (1) BR112012011017A2 (enExample)
CA (1) CA2780160C (enExample)
CL (1) CL2012001227A1 (enExample)
CO (1) CO6540004A2 (enExample)
DK (1) DK2498792T3 (enExample)
EC (1) ECSP12011967A (enExample)
ES (1) ES2645200T3 (enExample)
HR (1) HRP20171520T1 (enExample)
HU (1) HUE034617T2 (enExample)
IL (1) IL219483A (enExample)
LT (1) LT2498792T (enExample)
MX (1) MX2012005521A (enExample)
MY (1) MY162687A (enExample)
NO (1) NO2498792T3 (enExample)
NZ (1) NZ599559A (enExample)
PH (1) PH12012500913A1 (enExample)
PL (1) PL2498792T3 (enExample)
PT (1) PT2498792T (enExample)
RU (1) RU2680137C2 (enExample)
SI (1) SI2498792T1 (enExample)
UA (1) UA111147C2 (enExample)
WO (1) WO2011060083A1 (enExample)
ZA (1) ZA201203239B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014036165A1 (en) * 2012-08-29 2014-03-06 Bayer Healthcare, Llc Aqueous based compositions for treating otitis externa
CN104337952A (zh) * 2013-08-10 2015-02-11 李谊 一种中西医结合治疗爆震性耳聋的组合药物
CN104739768A (zh) * 2013-12-27 2015-07-01 河南惠通天下生物工程有限公司 一种甲砜霉素纳米脂质体及其制备方法
US11779538B2 (en) 2017-11-14 2023-10-10 Profem Gmbh Emulsions for treating mucous membrane infections
EP3482744A1 (de) * 2017-11-14 2019-05-15 ProFem GmbH Emulsionen zur topischen behandlung urogenitaler und dermaler infektionen
BR112022005354A2 (pt) * 2019-09-23 2022-08-23 Dds Res Inc Composições de vesícula lipídica com agentes potencializadores de penetração
EP4041153A4 (en) * 2019-10-11 2023-10-25 Piedmont Animal Health Inc. OTIC FORMULATIONS, METHODS AND DEVICES
CA3213099A1 (en) 2021-03-24 2022-09-29 Robert A. Love Peptides and methods for reducing skin pigmentation
CN113876658B (zh) * 2021-11-01 2023-10-20 仙乐健康科技股份有限公司 水包油型乳液组合物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU691249B2 (en) 1994-02-04 1998-05-14 Lipocore Holding Ab Bilayer preparations
AU3609795A (en) * 1994-10-10 1996-05-02 Novartis Ag Ophthalmic and aural compositions containing diclofenac potassium
WO1996039146A1 (en) * 1995-06-06 1996-12-12 Bayer Corporation Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions
IT1295369B1 (it) * 1997-10-21 1999-05-12 Fatro Spa Composizione a base di tiamfenicolo e diclofenac
US6433024B1 (en) * 2000-05-08 2002-08-13 Karl F. Popp Topical anti-acne composition
AUPR798901A0 (en) * 2001-09-28 2001-10-25 Medvet Science Pty. Ltd. Spheroidal hdl particles with a defined phospholipid composition
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US20050013854A1 (en) * 2003-04-09 2005-01-20 Mannino Raphael J. Novel encochleation methods, cochleates and methods of use
JP2007500691A (ja) * 2003-07-31 2007-01-18 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗炎症剤の分散性製剤
US20070054844A1 (en) * 2003-08-20 2007-03-08 Fairfield Clinical Trials, Llc Method for treating otitis externa
US20070078116A1 (en) 2003-08-20 2007-04-05 Fairfield Clinical Trials, Llc Method of treatment of otitis externa
US20050159369A1 (en) * 2003-08-20 2005-07-21 Qtm Llc Method of treatment of otitis externa
US20080124385A1 (en) 2004-09-03 2008-05-29 Piedmont Pharmaceuticals,Llc. Methods for Transmembrane Treatment and Prevention of Otitis Media
TW200719884A (en) 2005-03-10 2007-06-01 3M Innovative Properties Co Methods of treating ear infections
US20090082337A1 (en) 2007-09-21 2009-03-26 Srini Venkastesh Compositions Comprising Quinolone and Methods for Treating or Controlling Infections
US20090111780A1 (en) * 2007-10-31 2009-04-30 Everett Laboratories, Inc. Compositions and methods for treatment of ear canal infection and inflammation

Also Published As

Publication number Publication date
SI2498792T1 (sl) 2017-11-30
US20110281809A1 (en) 2011-11-17
ZA201203239B (en) 2013-07-31
IL219483A (en) 2017-12-31
RU2680137C2 (ru) 2019-02-18
RU2012124067A (ru) 2013-12-20
LT2498792T (lt) 2017-10-25
CA2780160A1 (en) 2011-05-19
UA111147C2 (uk) 2016-04-11
ECSP12011967A (es) 2012-08-31
PH12012500913A1 (en) 2012-11-26
NO2498792T3 (enExample) 2017-12-30
HUE034617T2 (en) 2018-02-28
AU2010319538A1 (en) 2012-05-17
JP6138891B2 (ja) 2017-05-31
MY162687A (en) 2017-07-14
PL2498792T3 (pl) 2018-01-31
DK2498792T3 (da) 2017-11-06
JP2013510861A (ja) 2013-03-28
WO2011060083A1 (en) 2011-05-19
HRP20171520T1 (hr) 2017-11-17
KR20170100680A (ko) 2017-09-04
PT2498792T (pt) 2017-10-18
ES2645200T3 (es) 2017-12-04
EP2498792A4 (en) 2013-06-12
CO6540004A2 (es) 2012-10-16
KR20120116398A (ko) 2012-10-22
KR101901083B1 (ko) 2018-09-20
EP2498792A1 (en) 2012-09-19
BR112012011017A2 (pt) 2015-09-15
EP2498792B1 (en) 2017-08-02
JP2016102112A (ja) 2016-06-02
CN102612372B (zh) 2016-01-20
MX2012005521A (es) 2012-06-19
CL2012001227A1 (es) 2012-08-24
IL219483A0 (en) 2012-06-28
AU2010319538B2 (en) 2015-04-09
US8927006B2 (en) 2015-01-06
CA2780160C (en) 2018-03-06
CN102612372A (zh) 2012-07-25

Similar Documents

Publication Publication Date Title
UA111147C2 (uk) Способи та композиції для лікування або профілактики зовнішнього отиту
US8361496B2 (en) Phospholipid gel compositions for drug delivery and methods of treating conditions using same
RU2014148284A (ru) Специально разработанные липосомы для лечения бактериальных инфекций
CO6260056A2 (es) Composiciones de liposomas para administracion in vivo de compuestos de acido boronico
JP2018184470A5 (enExample)
EA201200939A1 (ru) Липиды, липидные композиции и способы их применения
RU2019115688A (ru) Липосомальный препарат для применения для лечения злокачественного новообразования
RU2014120216A (ru) Комбинационные липосомальные композиции для лечения рака
EA201591662A1 (ru) Липиды и липидные композиции для доставки активных агентов
EP2317993A2 (en) Methods of administering topical antifungal formulations for the treatment of fungal infections
ES2916803T3 (es) Formulaciones vesiculares para su uso en el tratamiento del dolor o de la movilidad reducida de una articulación
JP2017514866A (ja) Ｂｒａｆ阻害剤を使用する創傷治癒
PE20050692A1 (es) Compuestos organicos
WO2020059543A1 (ja) 生体材料
US20150258043A1 (en) Use of sphingoid long chain bases and their analogs in treating and preventing bacterial infections
US7854943B2 (en) Phospholipid gel compositions for drug delivery and methods of treating conditions using same
AU2024206116A1 (en) Lipid conjugates for the delivery of therapeutic agents to adipose tissue
CN106456545A (zh) 免疫原性的脂质体制剂
JP2011504510A5 (enExample)
Schacht et al. Effects of neomycin on polyphosphoinositides in inner ear tissues and monomolecular films
TWI332007B (en) Use of alkylphosphocholines in combination with antitumor medicaments for the treatment of benign and malignant oncoses in humans and animals
De Castro et al. Antiprotozoal lysophospholipid analogues: a comparison of their activity against trypanosomatid parasites and tumor cells
Gaillard et al. Synthesis and evaluation of antitumor alkylphospholipid prodrugs
CO2023014991A2 (es) Lípidos catiónicos a base de tampones de good
VANRENSBURG et al. The antiproliferative riminophenazine agents clofazimine and b669 promote lysophospholipid-mediated inhibition of na+, k+-adenosine triphosphatase-activity in cancer cell-lines in-vitro

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 10 NOV 2017 BY COMPUTER PACKAGES INC

Effective date: 20150331

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 NOV 2018 BY CPA GLOBAL

Effective date: 20171019

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 NOV 2019 BY CPA GLOBAL

Effective date: 20181018

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 NOV 2020 BY CPA GLOBAL

Effective date: 20191017

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 NOV 2021 BY CPA GLOBAL

Effective date: 20201022

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 NOV 2022 BY THOMSON REUTERS

Effective date: 20211002

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 NOV 2023 BY THOMSON REUTERS

Effective date: 20221004

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 NOV 2024 BY THOMSON REUTERS

Effective date: 20231002

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 NOV 2025 BY ANAQUA SERVICES

Effective date: 20241022

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 NOV 2026 BY ANAQUA SERVICES

Effective date: 20251022